Literature DB >> 9334164

Interaction of platelet-derived growth factor with thrombospondin 1.

P J Hogg1, K A Hotchkiss, B M Jiménez, P Stathakis, C N Chesterman.   

Abstract

Key factors that mediate vascular smooth muscle cell proliferation and migration are platelet-derived growth factor (PDGF) and thrombospondin 1 (TSP1). We now report that PDGFBB bound tightly and specifically to TSP1, that this interaction was markedly dependent on the disulphide bond arrangement in TSP1, and that binding of PDGFBB to TSP1 did not preclude PDGFBB from binding to its receptor on rat aortic vascular smooth-muscle cells. At physiologic ionic strength and pH, PDGFBB bound to Ca2+-depleted TSP1 with a dissociation constant of 11 +/- 2 nM and to Ca2+-replete TSP1 with a dissociation constant of 32 +/- 5 nM. Binding was specific, as both soluble TSP1 and unlabelled PDGFBB competed for binding of iodinated PDGFBB to immobilized TSP1, whereas other platelet alpha-granule proteins did not compete. The tertiary structure of TSP1 is regulated by intramolecular disulphide interchange; we found that catalysis of disulphide interchange in TSP1 by protein disulphide isomerase ablated the binding of PDGFBB. The interaction of PDGFBB with TSP1 was weakened by increasing salt concentration and essentially ablated at 0.65 ionic strength; it was inhibited by heparin with a half-maximal effect at 20 i.u./ml, implying that the binding was mediated largely by ionic interactions. An anti TSP1 monoclonal antibody decreased the binding of iodinated PDGFBB to PDGF receptor on rat aortic vascular smooth-muscle cells by 37 +/- 2%, whereas platelet TSP1 non-competitively inhibited binding of iodinated PDGFBB. Uncomplexed PDGFBB bound to PDGF receptor with an affinity 5 +/- 2 times that of PDGFBB-TSP1 complexes. These results suggest that TSP1 might assist in the targeting of PDGF to its receptor on vascular smooth-muscle cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334164      PMCID: PMC1218752          DOI: 10.1042/bj3260709

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Transforming growth factor-beta complexes with thrombospondin.

Authors:  J E Murphy-Ullrich; S Schultz-Cherry; M Höök
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

2.  Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions.

Authors:  S T Olson; P E Bock; R Sheffer
Journal:  Arch Biochem Biophys       Date:  1991-05-01       Impact factor: 4.013

3.  Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.

Authors:  R Yabkowitz; V M Dixit
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

4.  Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.

Authors:  P Clezardin; L Frappart; M Clerget; C Pechoux; P D Delmas
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

5.  A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene.

Authors:  P Framson; P Bornstein
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

Review 6.  Platelet-derived growth factor and alternative splicing: a review.

Authors:  L M Khachigian; C N Chesterman
Journal:  Pathology       Date:  1992-10       Impact factor: 5.306

7.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.

Authors:  E W Raines; T F Lane; M L Iruela-Arispe; R Ross; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 8.  Structural and functional studies on platelet-derived growth factor.

Authors:  C H Heldin
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Role of the extracellular matrix protein thrombospondin in the early development of the mouse embryo.

Authors:  K S O'Shea; L H Liu; L H Kinnunen; V M Dixit
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

10.  Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin.

Authors:  X Sun; K Skorstengaard; D F Mosher
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  12 in total

Review 1.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

2.  Thrombospondin-1 binds to polyhistidine with high affinity and specificity.

Authors:  V K Vanguri; S Wang; S Godyna; S Ranganathan; G Liau
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 3.  Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Gábor Csányi; Patrick J Pagano; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2014-01-11       Impact factor: 11.583

4.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 5.  Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.

Authors:  Fabien Binamé
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

Review 6.  Allosteric disulfides: Sophisticated molecular structures enabling flexible protein regulation.

Authors:  Joyce Chiu; Philip J Hogg
Journal:  J Biol Chem       Date:  2019-01-10       Impact factor: 5.157

7.  Counterbalancing forces: what is thrombospondin-1 doing in atherosclerotic lesions?

Authors:  Olga I Stenina; Edward F Plow
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

Review 8.  Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.

Authors:  Zhi Huang; Shi-Deng Bao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 9.  Functions of Thrombospondin-1 in the Tumor Microenvironment.

Authors:  Sukhbir Kaur; Steven M Bronson; Dipasmita Pal-Nath; Thomas W Miller; David R Soto-Pantoja; David D Roberts
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 6.208

10.  Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells.

Authors:  Caterina Lande; Claudia Boccardi; Lorenzo Citti; Alberto Mercatanti; Milena Rizzo; Silvia Rocchiccioli; Lorena Tedeschi; Maria Giovanna Trivella; Antonella Cecchettini
Journal:  BMC Res Notes       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.